BACKGROUND
Recent research in humans and rodents has explored the use of deep brain stimulation (DBS) of the ventral capsule/ventral striatum (VS) as a possible treatment for drug addiction. However, the optimum electrode placement and optimum DBS parameters have not been thoroughly studied. Here we varied stimulation sites and frequencies to determine whether DBS of the VS could facilitate the extinction of morphine-induced conditioned place preference in rats.
Methods
Rats were implanted with DBS electrodes in the dorsal or ventral subregions of the VS and trained to the morphine-CPP. Subsequently, rats received extinction sessions over 9 days, combined with 60 min of either high (130 Hz) or low (20 Hz) frequency DBS. To study circuit-wide activations after DBS of the VS, c-fos immunohistochemistry was performed in regions involved in the extinction of drug seeking behaviors.
Results
High frequency DBS of the dorsal-VS impaired both extinction training and extinction memory, whereas high frequency DBS of the ventral-VS had no effect. In contrast, low frequency DBS of the dorsal-VS strengthened extinction memory when tested 2 or 9 days after the cessation of stimulation. Both DBS frequencies increased c-fos expression in the infralimbic prefrontal cortex, but only low frequency DBS increased c-fos expression in the basal amygdala and the medial portion of the central amygdala.
Conclusions
Our results suggest that low frequency (rather than high frequency) DBS of the dorsal-VS strengthens extinction memory and may be a potential adjunct for extinction-based therapies for treatment-refractory opioid addicts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.